MCM
CBPO

McKinley Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

McKinley Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,190
Closed -$666K – 577
2016
Q4 		$666K Sell
6,190
-230
-4% -$26.9K 0.03% 269
2016
Q3 		$799K Buy
6,420
+500
+8% +$59K 0.03% 261
2016
Q2 		$629K Buy
+5,920
New +$687K 0.03% 251

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

McKinley Capital Management's CBPO Position: Q1 2017 in Review

McKinley Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 6,190 shares — an estimated $666K sold.

McKinley Capital Management first reported a position in CBPO in Q2 2016 and held it in 3 quarters. The position peaked at $799K in Q3 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

  • McKinley Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
  • McKinley Capital Management sold 6,190 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $666K.
  • McKinley Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 3 quarters.
  • McKinley Capital Management's China Biologic Products Holdings, Inc. position peaked at $799K in Q3 2016.
  • 137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on McKinley Capital Management's 13F filing for Q1 2017, filed 10 May 2017.